How to Read VIP COA? (Certificate of Analysis Explained)
A Certificate of Analysis from a peptide supplier isn't optional paperwork. It's the only document standing between you and a vial of unknown purity. Research published in the Journal of Pharmaceutical Sciences found that unverified peptide samples submitted for independent testing showed contamination rates exceeding 40%, with some containing less than 60% of the stated compound. The COA is your verification that what you ordered matches what arrived.
Our team has reviewed thousands of peptide COAs across multiple suppliers. The difference between a legitimate research-grade compound and an under-spec batch comes down to three data points most researchers glance past: HPLC purity percentage, mass spectrometry confirmation, and endotoxin levels. This guide covers how to read VIP COA documents line by line, what each test result means for compound integrity, and which red flags indicate you should reject a batch before reconstitution.
How do you read a VIP Certificate of Analysis for peptides?
To read VIP COA documents, verify five critical data points: HPLC purity (should be ≥98% for research-grade peptides), mass spectrometry molecular weight match (must align with the expected compound within 0.5 Da), endotoxin levels (≤1.0 EU/mg), peptide content by weight (confirms dosing accuracy), and batch-specific testing date. Each metric validates a different aspect of manufacturing quality. Missing any one compromises research reliability.
The COA isn't a summary. It's raw analytical data from third-party testing labs. If a supplier doesn't provide COAs or provides generic placeholder documents, that's not an oversight. It's a signal they're not testing their compounds at all. The rest of this article covers what HPLC chromatography actually measures, how mass spec confirms molecular identity, why endotoxin testing matters for injectable peptides, what purity percentages mean in practical terms, and which COA formats indicate batch-specific verification versus template reuse.
Step 1: Verify HPLC Purity Percentage Before Anything Else
HPLC (High-Performance Liquid Chromatography) purity is the first number to check on any peptide COA. It tells you what percentage of the vial's contents is the actual peptide you ordered versus impurities, truncated sequences, or residual synthesis byproducts. Research-grade peptides should show ≥98% purity; therapeutic-grade compounds require ≥99%. Anything below 95% indicates the synthesis process failed quality control or the compound degraded during storage.
The HPLC chromatogram. The graph printed on most COAs. Shows retention time on the X-axis and UV absorbance on the Y-axis. The tallest peak represents your target peptide; smaller peaks are impurities. Calculate purity by dividing the area under the main peak by the total area under all peaks. A COA that lists '98.4% purity' without showing the actual chromatogram is unverifiable. The percentage could be fabricated or rounded from a much lower value.
Impurities at 2–5% aren't always inert filler. Truncated peptide sequences (missing one or more amino acids) can bind to the same receptors as your target compound but with unpredictable affinity, creating dosing inconsistency. Deletion sequences (des-amino variants) are common in GLP-1 analogs like semaglutide and tirzepatide when synthesis rushed through coupling steps. Real Peptides subjects every batch to full HPLC analysis before release. Rejecting any lot that falls below 98% even if it technically meets the 95% industry minimum.
Step 2: Confirm Molecular Weight Match Using Mass Spectrometry Data
Mass spectrometry (MS) is the second critical verification. It confirms the peptide's molecular weight matches the expected structure down to the atomic level. HPLC tells you purity; MS tells you identity. A vial could be 99% pure but still be the wrong compound entirely if the synthesis assembled the wrong amino acid sequence. MS catches that.
The COA should list both the expected molecular weight (calculated from the peptide's amino acid formula) and the observed molecular weight (measured by the MS instrument). For research-grade peptides, these values must match within ±0.5 Daltons (Da). A 3,000 Da peptide with an observed weight of 3,002.8 Da is within acceptable tolerance; one showing 2,987 Da or 3,015 Da suggests synthesis errors, degradation, or contamination with a related but distinct compound.
ESI-MS (Electrospray Ionization Mass Spectrometry) is the standard method for peptides under 10,000 Da. The technique ionizes the peptide and measures its mass-to-charge ratio. Multiple charge states appear as separate peaks. The calculation accounts for this. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) is used for larger peptides and proteins. Both methods are valid; what matters is the molecular weight confirmation, not the technique. If the COA lists only HPLC purity without MS data, you cannot verify you received the correct peptide. Reject the batch.
Step 3: Check Endotoxin Levels for Any Injectable Research Compound
Endotoxin testing measures bacterial contamination that survives the synthesis and lyophilization process. Specifically lipopolysaccharides (LPS) from gram-negative bacteria like E. coli. Even sterilized peptides can contain endotoxins because the molecules themselves are heat-stable and survive autoclaving. For injectable peptides, endotoxin levels must be ≤1.0 EU/mg (Endotoxin Units per milligram); therapeutic-grade compounds require ≤0.5 EU/mg.
The LAL (Limulus Amebocyte Lysate) assay is the standard test. It uses blood cells from horseshoe crabs that clot in the presence of endotoxins. The COA should state the method (kinetic chromogenic LAL, gel-clot LAL, or recombinant Factor C) and the result in EU/mg. Endotoxin contamination at 5–10 EU/mg won't cause immediate visible infection but triggers systemic inflammation. Fever, joint pain, and immune activation that can skew research results involving inflammatory pathways or metabolic studies.
Oral peptides like orforglipron carry lower endotoxin risk because gastric acid denatures LPS before systemic absorption. Injectable peptides. Semaglutide, tirzepatide, BPC-157, thymosin beta-4. Bypass that protective barrier. If the COA omits endotoxin testing entirely, assume the peptide wasn't tested. Suppliers producing compounds for research use in academic or clinical settings are required to test every batch; consumer-facing suppliers often skip this step to reduce costs.
VIP COA: Document Type Comparison
| Document Type | What It Verifies | Testing Standard | When to Accept | When to Reject |
|---|---|---|---|---|
| Batch-Specific COA | HPLC purity, MS molecular weight, endotoxin level, peptide content for the exact lot number you received | Third-party lab testing (e.g., Colmaric Analyticals, Eurofins) with dated results | Lot number on vial matches COA lot number; testing date is within 6 months of manufacture date | Generic template reused across batches; no lot number match; testing older than 12 months |
| Manufacturer Internal COA | HPLC and MS only, tested in-house by the peptide supplier | In-house analytical lab using validated methods (ISO 17025 accredited) | Acceptable for preliminary verification if third-party COA is pending; purity ≥98% | Only document provided; no third-party verification available; results inconsistent with product performance |
| Generic Template COA | Placeholder document listing expected specifications without actual test results | No testing performed. Template filled with target values | Never acceptable for research-grade compounds | Supplier refuses to provide batch-specific data; COA is a PDF with editable fields; same document across multiple orders |
| Third-Party Verification COA | Full panel testing by an independent analytical lab unaffiliated with the manufacturer | ISO/IEC 17025 accredited lab testing (Colmaric, SGS, Eurofins, ALS) | Gold standard. Accept when lot number matches and testing includes HPLC, MS, endotoxin, and peptide content | Lab accreditation cannot be verified; testing date precedes stated manufacture date (impossible unless fabricated) |
| Research Use Only Disclaimer COA | Standard COA with legal disclaimer stating compound is not for human or veterinary use | Same as batch-specific COA but with regulatory compliance language | Accept as equivalent to batch-specific COA if all analytical data is present | Disclaimer is present but analytical data is missing or incomplete. Disclaimer alone does not validate quality |
Key Takeaways
- HPLC purity percentage is the first verification point. Research-grade peptides require ≥98% purity, with the chromatogram showing a single dominant peak and minimal impurity signals.
- Mass spectrometry confirms molecular identity by matching observed molecular weight to the expected peptide structure within ±0.5 Da. Purity alone cannot verify you received the correct compound.
- Endotoxin levels must be ≤1.0 EU/mg for injectable peptides to prevent systemic inflammation and immune activation that can interfere with research outcomes.
- Batch-specific COAs include a lot number that matches the vial label. Generic template COAs with no lot number or testing date are unverifiable and should be rejected.
- Peptide content by weight (stated as mg per vial) confirms accurate dosing. A vial labeled '5mg' should contain 5.0 ±0.5 mg when tested, not 3.2 mg or 6.8 mg.
- Third-party lab testing from ISO 17025 accredited facilities (Colmaric, Eurofins, SGS) provides independent verification that in-house testing cannot match.
What If: VIP COA Scenarios
What If the COA Shows 96% Purity Instead of 98%?
Accept the batch only if your research protocol tolerates impurities at that level and the MS data confirms correct molecular weight. A 96% pure peptide means 4% of the vial's mass is something other than your target compound. Truncated sequences, deletion analogs, or synthesis byproducts. For dose-response studies or receptor binding assays, that 4% introduces uncontrolled variables. For general metabolic research where precise receptor occupancy isn't critical, 96% may be acceptable. Verify the impurity peaks on the HPLC chromatogram are small and distributed. Not one large secondary peak indicating a major synthesis failure.
What If the Lot Number on the Vial Doesn't Match the COA?
Reject the batch immediately and contact the supplier for the correct COA. A lot number mismatch means you cannot verify the document corresponds to your product. The COA could be from a different batch with different purity, or a generic template. Suppliers sometimes ship older inventory and provide COAs from newer batches to present better test results. Request the batch-specific COA matching your vial's lot number before reconstituting anything.
What If the COA Omits Endotoxin Testing?
Contact the supplier and request endotoxin data before using the peptide for any injectable application. Oral compounds like orforglipron tablets carry lower risk; injectable peptides like semaglutide, BPC-157, or thymosin beta-4 require endotoxin verification. If the supplier cannot provide it, assume the batch wasn't tested. Using peptides with unknown endotoxin levels in research introduces uncontrolled inflammatory variables that can invalidate metabolic, immune, or cardiovascular studies.
The Uncomfortable Truth About Peptide COAs
Here's the honest answer: most consumer-facing peptide suppliers don't conduct third-party testing on every batch. They test once during initial compound validation, then reuse that COA across dozens of subsequent batches to avoid the $500–$1,200 per-batch testing cost. The result is a document that looks legitimate but doesn't verify the specific vial in your hand.
The giveaway is a COA with no lot number or a testing date that's 18 months old. Peptides degrade over time. Even when lyophilized and stored correctly, purity drops 1–3% per year due to oxidation and hydrolysis. A COA from 2024 doesn't verify a vial manufactured in 2026. Suppliers betting you won't notice the discrepancy rely on customers not understanding what batch-specific verification means.
We mean this sincerely: if a supplier can't provide a COA dated within six months of your order and matching your vial's lot number, find a different supplier. The cost difference between verified and unverified peptides is $20–$40 per vial. Trivial compared to the research hours wasted on inconsistent dosing or contaminated compounds. Every peptide batch at Real Peptides undergoes third-party HPLC, MS, and endotoxin testing before release, with results posted to the product page within 48 hours of manufacture. That's not a premium service. It's the baseline standard for research-grade compounds.
The broader issue is regulatory ambiguity. Peptides sold as 'research chemicals' aren't subject to FDA pharmaceutical manufacturing standards, so quality verification is voluntary. Suppliers can legally sell 85% pure peptides as long as they don't make therapeutic claims. The COA is your only protection. And only if you know how to read it. The five-minute investment in verifying purity, molecular weight, and endotoxin levels before reconstitution saves months of troubleshooting inconsistent research outcomes later.
If the COA shows your peptide passed every verification test. HPLC purity ≥98%, mass spec within tolerance, endotoxin ≤1.0 EU/mg, and peptide content matching the label. You can reconstitute with confidence. Anything less means you're working with an unknown variable, not a controlled research tool.
Frequently Asked Questions
What does HPLC purity percentage mean on a peptide COA?▼
HPLC purity measures what percentage of the vial’s contents is the actual target peptide versus impurities, truncated sequences, or synthesis byproducts. Research-grade peptides should show ≥98% purity, calculated by dividing the area under the main chromatogram peak by the total area under all peaks. Purity below 95% indicates synthesis failure or degradation.
How do I verify the molecular weight on a mass spectrometry COA?▼
Check that the observed molecular weight matches the expected molecular weight within ±0.5 Daltons. The expected weight is calculated from the peptide’s amino acid sequence; the observed weight is measured by the MS instrument. A mismatch larger than 0.5 Da suggests you received the wrong compound, a degraded peptide, or a contaminated sample.
What is a safe endotoxin level for injectable peptides?▼
Injectable peptides must contain ≤1.0 EU/mg (Endotoxin Units per milligram) for research use; therapeutic-grade compounds require ≤0.5 EU/mg. Endotoxins are bacterial lipopolysaccharides that survive sterilization and cause systemic inflammation even at low levels. LAL assay testing verifies endotoxin concentration on every batch.
Can I trust a COA if the lot number doesn’t match my vial?▼
No — a lot number mismatch means the COA does not verify your specific batch and could be from a different production run with different purity levels. Always reject batches when the COA lot number doesn’t match the vial label, and request the correct batch-specific COA from your supplier before use.
What is the difference between batch-specific and generic COAs?▼
Batch-specific COAs include test results from the exact lot you received, with matching lot numbers and recent testing dates. Generic COAs are template documents listing target specifications without actual test data — they’re often reused across multiple batches to avoid per-batch testing costs. Only batch-specific COAs verify your compound’s quality.
Why do some peptide COAs omit endotoxin testing?▼
Endotoxin testing adds $150–$300 per batch to manufacturing costs, so some suppliers skip it to reduce prices. This is acceptable for oral peptides but dangerous for injectables, where endotoxins bypass gastric acid and cause systemic inflammation. If your COA omits endotoxin data and you’re using the compound for injection, request testing or switch suppliers.
How recent should the testing date be on a peptide COA?▼
The testing date should be within six months of your order date, or within one year of the stated manufacture date at most. Lyophilized peptides degrade 1–3% per year even with proper storage, so a COA from 2024 doesn’t verify a vial manufactured in 2026. Older testing dates suggest the supplier is reusing old documents instead of conducting batch-specific testing.
What does peptide content by weight verify on a COA?▼
Peptide content confirms the vial contains the stated amount of active compound by mass — not just lyophilized powder weight including fillers. A vial labeled ‘5mg’ should contain 5.0 ±0.5 mg of peptide when tested, ensuring accurate dosing. Content verification catches underfilled vials or excessive filler use that would dilute your working concentration.
Can HPLC purity alone confirm I received the correct peptide?▼
No — HPLC measures purity but not identity. A vial could be 99% pure but contain the wrong peptide entirely if synthesis assembled the incorrect amino acid sequence. Mass spectrometry is required to confirm molecular weight matches the expected structure, verifying you received the compound you ordered.
Which third-party labs are accredited for peptide COA testing?▼
ISO/IEC 17025 accredited labs like Colmaric Analyticals, Eurofins, SGS, and ALS provide independent peptide verification. These labs conduct HPLC, mass spectrometry, and endotoxin testing without affiliation to peptide manufacturers, eliminating conflicts of interest that can compromise in-house testing accuracy. Verify lab accreditation before accepting third-party COAs.
